Avecho Biotechnology Ltd V.AVE

Primary Symbol: AVEFF

Healthcare

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.

OTCPK:AVEFF - Post by User

Avecho Biotechnology Ltd > Bruce Campbell comments on BNN market call tonight

<< Previous

Bullboard Posts

Next >>

Comment by retiredcfon Nov 09, 2017 7:34am

180 Views

Post# 26930993

RE:Bruce Campbell comments on BNN market call tonight

2017-11-08 COMMENT Bruce Campbell (2)

This business is interesting, especially if you look at 2 data points. One is the number of rigs that are working in the US, and 2 is the price of oil. They’ve been trying to consolidate a fairly fragmented business in the US. US energy companies are looking for service companies that are bigger and can operate in more territory, not necessarily mom-and-pop operations. The new management comes from big oil companies and have relationships. He expects the numbers, when they report, will be fairly good.

Price:

$0.600

Subject:

CANADIAN

Bias:

UNKNOWN

Owned:

Unknown

<< Previous

Bullboard Posts

Next >>

Catch up with companies that got a Stanley Cup Playoffs boost